InsidersTradesSigma
Track the 엔젠바이오 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are quoted on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, 엔젠바이오 has logged 3 insider filings. Market capitalisation: €17.6bn. The latest transaction was reported on 26 June 2026 (Sale). Among the most active insiders: 에스에이치헬스케어투자1호조합. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
Enzenbio es una empresa especializada en el sector de la salud y farmacéutico, que cotiza en el mercado XKRX. Se centra en el desarrollo de soluciones biofarmacéuticas innovadoras.